首页 | 本学科首页   官方微博 | 高级检索  
检索        

下咽癌根治性调强放疗联合化疗30例临床观察
引用本文:姜翠红,吴湘玮,刘雯,肖帅,贺礼理,曾彪.下咽癌根治性调强放疗联合化疗30例临床观察[J].医学临床研究,2014,0(7):1306-1309.
作者姓名:姜翠红  吴湘玮  刘雯  肖帅  贺礼理  曾彪
作者单位:姜翠红 (湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院头颈放疗科,湖南 长沙,410013); 吴湘玮 (湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院头颈放疗科,湖南 长沙,410013); 刘雯 (湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院头颈放疗科,湖南 长沙,410013); 肖帅 (湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院头颈放疗科,湖南 长沙,410013); 贺礼理 (湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院头颈放疗科,湖南 长沙,410013); 曾彪 (湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院头颈放疗科,湖南 长沙,410013);
摘    要:【目的】探讨下咽癌手术及放化疗的临床效果。【方法】回顾性分析2008年6月至2010年10月本院收治的70例下咽癌病例的临床资料,70例患者根据2002年国际抗癌联盟分期标准,Ⅰ期3例,Ⅱ期10例,Ⅲ期22例,Ⅳ期35例。根据不同的治疗方法,将70例患者分为两组,根治性调强放疗+化疗组(A组,30例),手术+术后常规放疗组(B组,40例),术后2~4周伤口完全愈合后进行放疗,比较两组治疗后总生存率和局部控制率。【结果】70例患者的1、3、5年总生存率分别为82.9%(58/70),61.5%(43/70),38.5%(27/70)。A组和B组局部控制率分别为66.7%(20/30),70.0%(28/40),两组相比较差异无显著性( P >0.05)。A组和B组1、3、5年总生存率分别为83.3%(25/30),63.0%(19/30),38.0%(11/30)和82.5%(33/40),58.5%(23/40),39.0%(15/40)。两组1、3、5年生存率相比较差异均无显著性( P >0.05)。【结论】根治性调强放疗+化疗能获得同手术一样的疗效,且更好地保留了患者的喉功能,提高了生活质量。

关 键 词:下咽肿瘤  外科学  下咽肿瘤  药物疗法  下咽肿瘤  放射疗法  预后

Clinical Analysis of Comprehensive Therapy for 70 Patients with Hypopharyngeal Carcinoma
Institution:JIANG Cui-hong, WU Xiang-wei, LIU Wen (Department of Radiotherapy for Head and Neck, Affiliated Timor Hospital, Xiangya Medical School, Central South University, Changsha 410013, China )
Abstract:Objective To explore the efficacy and prognostic factors of comprehensive therapy for hypopharyngeal carcinoma .Methods]Clinical data of 70 patients with hypopharyngeal carcinoma in our hospital from June 2008 to Oct . 2010 were analyzed retrospectively .According to 2002 international union against cancer (UICC) staging standard ,3 patients were stageⅠ,and 10 patients were stageⅡ ,and 22 patients were stage Ⅲ and 35 patients were stage IV .According to different treatment methods ,70 patients were divided into radical intensity modulated radiation therapy plus chemotherapy group(group A ,n=30) and surgery plus postoperative routine radiation group (group B ,n=40) .Radiotherapy was given 2~4 weeks after the complete healing of postoperative wound .Results] The 1-,3- and 5-year overall survival rates of all 70 patients were 82 .9% (58/70) ,61 .5% (43/70) and 38 .5% (27/70) ,respectively .The local control rates of group A and group B were 66 .7% (20/30) and 70 .0% (28/40) respectively ,but there was no significant difference between two groups( P〉0 .05) .The 1-,3-and 5-year overall survival rates of group A and group B were 83 .3% (25/30) ,63 .0% (19/30) ,38 .0% (11/30) ,82 .5% (33/40) ,58 .5% (23/40) and 39 .0% (15/40) respectively ,but there was no significant difference between two groups ( P〉0 .05) .Conclusion]Radical intensity modulated radiation therapy combined with chemotherapy can not only obtain the same efficacy as surgery ,but also keep the laryngeal function of patients and improve the quality of life .
Keywords:Hypopharyngeal Neoplasms/surgery  Hypopharyngeal Neoplasms/drug therapy  Hypo-pharyngeal Neoplasms/radiotherapy  Prognosis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号